🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study was designed to evaluate the safety, tolerability, pharmacodynam...
Status
Active Not Recruiting
Location
Clínica Imbanaco S.A.S
Start Date
2015-10-29
Trial ID
NCT02562235
Treatments Being Tested
To demonstrate the effectiveness of riociguat as replacement of phosphodies...
Status
Completed
Location
Multiple Locations
Start Date
2017-01-11
Trial ID
NCT02891850
Treatments Being Tested
This is a study to demonstrate the feasibility of an individual dose titrat...
Status
Completed
Location
Multiple Locations
Start Date
2007-01
Trial ID
NCT00454558
Treatments Being Tested
To evaluate the efficacy and safety of 26-weeks of treatment with riociguat...
Status
Terminated
Location
University of California, Los Angeles
Start Date
2014-06-04
Trial ID
NCT02138825
Treatments Being Tested
BAY63-2521 Riociguat leads to the relaxation of smooth muscle cells in pulm...
Status
Completed
Location
Multiple Locations
Start Date
2014-02-18
Trial ID
NCT02007629
Treatments Being Tested
The aim of the study is to assess the efficacy and safety of different dose...
Status
Completed
Location
Multiple Locations
Start Date
2009-02-23
Trial ID
NCT00855465
Treatments Being Tested
Pulmonary Arterial Hypertension (PAH) is a severe progressive disease with ...
Status
Completed
Location
Multiple Locations
Start Date
2010-08
Trial ID
NCT01179334
Treatments Being Tested
This study is to demonstrate the safety, tolerability, pharmakokinetic and ...
Status
Completed
Location
Multiple Locations
Start Date
2008-08
Trial ID
NCT00640315
Treatments Being Tested
The MOTION study was a prospective, Phase IV study for patients with Pulmon...
Status
Completed
Location
Multiple Locations
Start Date
2014-09-23
Trial ID
NCT02191137
Treatments Being Tested
This study is to demonstrate the safety, tolerability, pharmakokinetic and ...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT00680654
Treatments Being Tested